{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:47:21Z","timestamp":1792097241136,"version":"4.4.0"},"reference-count":154,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2013,10,10]],"date-time":"2013-10-10T00:00:00Z","timestamp":1381363200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJERPH"],"abstract":"<jats:p>Tobacco use is strongly associated with a variety of psychiatric disorders. Smokers are more likely than non-smokers to meet current criteria for mental health conditions, such as mood disorders, anxiety disorders and psychosis. Evidence also suggest that smokers with psychiatric disorders may have more difficulty quitting, offering at least a partial explanation for why smoking rates are higher in this population. The mechanisms linking mental health conditions and cigarette smoking are complex and likely differ across each of the various disorders. The most commonly held view is that patients with mental health conditions smoke in an effort to regulate the symptoms associated with their disorder. However some recent evidence suggests that quitting smoking may actually improve mental health symptoms. This is particularly true if the tobacco cessation intervention is integrated into the context of ongoing mental health treatment. In this paper we reviewed and summarized the most relevant knowledge about the relationship between tobacco use and dependence and psychiatric disorders. We also reviewed the most effective smoking cessation strategies available for patients with psychiatric comorbidity and the impact of smoking behavior on psychiatric medication.<\/jats:p>","DOI":"10.3390\/ijerph10104790","type":"journal-article","created":{"date-parts":[[2013,10,10]],"date-time":"2013-10-10T14:11:12Z","timestamp":1381414272000},"page":"4790-4811","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":80,"title":["Smoking Behaviour and Mental Health Disorders\u2014Mutual Influences and Implications for Therapy"],"prefix":"10.3390","volume":"10","author":[{"given":"Amedeo","family":"Minichino","sequence":"first","affiliation":[{"name":"Department of Neurology and Psychiatry, Sapienza University of Rome, Rome 00185, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Bersani","sequence":"additional","affiliation":[{"name":"Department of Neurology and Psychiatry, Sapienza University of Rome, Rome 00185, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanda","family":"Cal\u00f2","sequence":"additional","affiliation":[{"name":"Department of Neurology and Psychiatry, Sapienza University of Rome, Rome 00185, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Spagnoli","sequence":"additional","affiliation":[{"name":"Department of Neurology and Psychiatry, Sapienza University of Rome, Rome 00185, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Francesconi","sequence":"additional","affiliation":[{"name":"Department of Neurology and Psychiatry, Sapienza University of Rome, Rome 00185, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Vicinanza","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular, Respiratory, Nephrologic and Geriatric Sciences, Sapienza University, Rome 00185, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Delle Chiaie","sequence":"additional","affiliation":[{"name":"Department of Neurology and Psychiatry, Sapienza University of Rome, Rome 00185, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Biondi","sequence":"additional","affiliation":[{"name":"Department of Neurology and Psychiatry, Sapienza University of Rome, Rome 00185, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2013,10,10]]},"reference":[{"key":"ref_1","unstructured":"(2004). The Health Consequences of Smoking: A Report of the Surgeon General, U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Centre for Cronic Disease Prevention and Health Promotion, Office on Smoking and Health."},{"key":"ref_2","unstructured":"Minino, A.M., Arias, E., Kochanek, K.D., Murphy, S.L., and Smith, B.L. Deaths: Final Data for 2000. Available online:http:\/\/www.cdc.gov\/nchs\/products\/nvsr.htm."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1001\/jama.293.3.293","article-title":"Correction: Actual causes of death in the United States, 2000","volume":"293","author":"Mockdad","year":"2005","journal-title":"JAMA"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/BF02196920","article-title":"Psychiatric comorbidity of smoking and nicotine dependance","volume":"25","author":"Breslao","year":"1995","journal-title":"Behav. Genet."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1080\/14622200110050457","article-title":"The relationship between tobacco use, substance-use disorders and mental health: Results from the National Survey of Mental Health and Well-Being","volume":"3","author":"Degenhardt","year":"2001","journal-title":"Nicotine Tob. Res."},{"key":"ref_6","first-page":"1","article-title":"Depression and smoking in the U.S. household population aged 20 and over, 2005\u20132008","volume":"34","author":"Pratt","year":"2010","journal-title":"NCHS Data Briefs"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1001\/jama.284.20.2606","article-title":"Smoking and mental illness: A population-based prevalence study","volume":"284","author":"Lasser","year":"2000","journal-title":"JAMA"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1037\/0893-164X.22.1.122","article-title":"Nicotine withdrawal in smokers with current depressive disorders undergoing intensive smoking cessation treatment","volume":"22","author":"Blalock","year":"2008","journal-title":"Psychol. Addict. Behav."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"503","DOI":"10.4088\/JCP.v62n07a01","article-title":"Bupropion sustained release as a smoking cessation treatment in remitted depressed patients maintained on treatment with selective serotonin reuptake inhibitor antidepressants","volume":"2","author":"Chengappa","year":"2001","journal-title":"J. Clin. Psychiatr."},{"key":"ref_10","unstructured":"Peterson, A.L., Vander Weg, M.W., and Jaen, C.R. (2011). Nicotine and Tobacco Dependence, Hogrefe Publishing."},{"key":"ref_11","unstructured":"The Health Consequences of Smoking: Nicotine Addiction: A Report of the Surgeon General. Available online:http:\/\/www.profiles.nlm.nih.gov\/NN\/B\/B\/Z\/D\/\/nnbbzd.pdf."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/00004583-200402000-00016","article-title":"Bupropion SR in adolescents with comorbid ADHD and nicotine dependence: A pilot study","volume":"43","author":"Upadhyaya","year":"2004","journal-title":"J. Am. Acad. Child Adolesc. Psychiatr."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/clpt.1988.107","article-title":"Nicotine absorption and cardiovascular effects with smokeless tobacco use: Comparison with cigarettes and nicotine gum","volume":"44","author":"Benowitz","year":"1988","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.bcp.2009.06.098","article-title":"Insight in nAChR subtype selectivity from AChBP crystal structures","volume":"78","author":"Rucktooa","year":"2009","journal-title":"Biochem. Pharmacol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0006-3223(96)00302-2","article-title":"Increased levels of the nicotine metabolite cotinine in schizophrenic smokers compared to other smokers","volume":"42","author":"Olincy","year":"1997","journal-title":"Biol. Psychiatr."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0899-3289(95)90030-6","article-title":"Cigarette smoking in adult patients diagnosed with attention deficit hyperactivity disorder","volume":"7","author":"Pomerleau","year":"1995","journal-title":"J. Subst. Abuse."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0014-2999(00)00122-9","article-title":"Role of dopamine in the behavioural actions of nicotine related to addiction","volume":"393","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1080\/14622200802443569","article-title":"Tobacco use and cessation in psychiatric disorders: National Institute of Mental Health report","volume":"10","author":"Ziedonis","year":"2008","journal-title":"Nicotine Tob. Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1046\/j.1360-0443.2003.00295.x","article-title":"A meta-analysis of estimated genetic and environmental effects on smoking behavior in male and female adult twins","volume":"98","author":"Li","year":"2003","journal-title":"Addiction"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0924-977X(95)00056-U","article-title":"Differential actions of typical and atypical antipsychotic drugs on dopamine release in the core and shell of the nucleus accumbens","volume":"6","author":"Marcus","year":"1996","journal-title":"Eur. Neuropsychopharmacol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.neubiorev.2010.02.006","article-title":"Neurobiological mechanisms involved in nicotine dependence and reward: Participation of the endogenous opioid system","volume":"35","author":"Berrendero","year":"2010","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1111\/j.1360-0443.2010.03002.x","article-title":"Association of adolescent symptoms of depression and anxiety with daily smoking and nicotine dependence in young adulthood: Findings from a 10-year longitudinal study","volume":"105","author":"McKenzie","year":"2010","journal-title":"Addiction"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1146\/annurev.pharmtox.40.1.431","article-title":"Nicotinic receptors at the aminoacid level","volume":"40","author":"Corringer","year":"2000","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"ref_24","first-page":"46","article-title":"Cognitive-behavioral approaches to ADHD treatment in adulthood","volume":"67","author":"Safren","year":"2006","journal-title":"J. Clin. Psychiatr."},{"key":"ref_25","first-page":"31","article-title":"A subtype of nicotinic cholinergic receptor in rat brain is composed of alpha 4 and beta 2 subunits and is up-regulated by chronic nicotine treatment","volume":"41","author":"Flores","year":"1992","journal-title":"Mol. Pharmacol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S0165-6147(00)01979-9","article-title":"Nicotine addiction: The possible role of functional upregulation","volume":"23","author":"Buisson","year":"2002","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0091-3057(01)00651-7","article-title":"Neurobiology of the nicotine withdrawal syndrome","volume":"70","author":"Kenny","year":"2001","journal-title":"Pharmacol. Biochem. Behav."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/cne.10138","article-title":"Expression of neuronal nicotinic acetylcholine receptor subunit mRNAs within midbrain dopamine neurons","volume":"444","author":"Azam","year":"2002","journal-title":"J. Comp. Neurol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1093\/ntr\/nts201","article-title":"Development of novel pharmacotherapeutics for tobacco dependence: Progress and future directions","volume":"14","author":"Harmey","year":"2012","journal-title":"Nicotine Tob. Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14622200701188919","article-title":"Effects of abstinence from tobacco: Valid symptoms and time course","volume":"9","author":"Hughes","year":"2007","journal-title":"Nicotine Tob. Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.neubiorev.2011.06.007","article-title":"Smoking, quitting, an psychiatric disease: A review","volume":"36","author":"Aubin","year":"2012","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref_32","unstructured":"(1994). Diagnostic and Statistical Manual of Mental Disorder, American Psychiatric Association. [4th ed.]."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.schres.2005.02.010","article-title":"A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors","volume":"76","author":"Diaz","year":"2005","journal-title":"Schizophr. Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1176\/ajp.156.11.1751","article-title":"Smoking habits, current symptoms, and premorbid characteristics of schizophrenic patients in Nithsdale, Scotland","volume":"156","author":"Kelly","year":"1999","journal-title":"Am. J. Psychiatr."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1192\/bjp.177.3.212","article-title":"Causes of the excess mortality of schizophrenia","volume":"177","author":"Brown","year":"2000","journal-title":"Br. J. Psychiatr."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1093\/schbul\/sbp152","article-title":"Cigarette smoking and mortality risk in people with schizophrenia","volume":"37","author":"Kelly","year":"2011","journal-title":"Schizophr. Bull."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/BF02245149","article-title":"The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine","volume":"107","author":"Corrigal","year":"1992","journal-title":"Psychopharmacology"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0959-4388(97)80092-X","article-title":"Neurobiology of schizophrenia","volume":"7","author":"Egan","year":"1997","journal-title":"Curr. Opin. Neurobiol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1176\/ajp.150.12.1856","article-title":"Normalization of auditory physiology by cigarette smoking in schizophrenic patients","volume":"150","author":"Adler","year":"1993","journal-title":"Am. J. Psychiatr."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/0006-3223(94)00252-X","article-title":"Evidence in postmortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia","volume":"38","author":"Freedman","year":"1995","journal-title":"Biol. Psychiatr."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/0006-3223(92)90073-9","article-title":"Normalization by nicotine of deficient auditory sensory gating in the relatives of schizophrenics","volume":"32","author":"Adler","year":"1992","journal-title":"Biol. Psychiatr."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/1096-8628(20010108)105:1<20::AID-AJMG1047>3.0.CO;2-C","article-title":"Linkage disequilibrium for schizophrenia at the chromosome 15q13-14 locus of the alpha7-nicotinic acetylcholine receptor subunit gene (CHRNA7)","volume":"105","author":"Freedman","year":"2001","journal-title":"Am. J. Med. Genet."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0079-6123(00)26022-6","article-title":"Reward deficiency syndrome: Genetic aspects of behavioral disorders","volume":"126","author":"Comings","year":"2000","journal-title":"Prog. Brain Res."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Tsoi, D.T., Porwal, M., and Webster, A.C. (2013). Interventions for smoking cessation and reduction in individuals with schizophrenia. Cochrane Database Syst. Rev., 2.","DOI":"10.1002\/14651858.CD007253.pub3"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/382255a0","article-title":"Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs","volume":"382","author":"Pontieri","year":"1996","journal-title":"Nature"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1177\/002221949803100603","article-title":"Prospective study of tobacco smoking and substance dependencies among samples of ADHD and non-ADHD participants","volume":"31","author":"Lambert","year":"1998","journal-title":"J. Learn Disabil."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1037\/0021-843X.112.3.497","article-title":"Childhood predictors of adolescent substance use in a longitudinal study of children with ADHD","volume":"112","author":"Molina","year":"2003","journal-title":"J. Abnorm. Sychol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1097\/00004583-199007000-00007","article-title":"The adolescent outcome of hyperactive children diagnosed by research criteria: I. An 8-year prospective follow-up study","volume":"29","author":"Barkley","year":"1990","journal-title":"J. Am. Acad. Child Adolesc. Pychiatr."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1001\/archpsyc.62.10.1142","article-title":"Association between smoking and attention-deficit\/hyperactivity disorder symptoms in a population-based sample of young adults","volume":"62","author":"Kollins","year":"2005","journal-title":"Arch. Gen. Psychiatr."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.biopsych.2004.11.024","article-title":"Molecular genetics of attention-deficit\/hyperactivity disorder","volume":"57","author":"Faraone","year":"2005","journal-title":"Biol. Psychiatr."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/j.1399-0004.2004.00302.x","article-title":"Progress in searching for susceptibility loci and genes for smoking-related behaviour","volume":"66","author":"Li","year":"2004","journal-title":"Clin. Genet."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1001\/archpsyc.58.6.573","article-title":"Incidence of cancer among persons with schizophrenia and their relatives","volume":"58","author":"Lichtermann","year":"2001","journal-title":"Arch. Gen. Psychiatr."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1002\/neu.10148","article-title":"Cellular and synaptic mechanisms of nicotine addiction","volume":"53","author":"Mansvelder","year":"2002","journal-title":"J. Neurobiol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/syn.890160105","article-title":"Systemic nicotine-induced dopaminerelease in the rat nucleus accumbens is regulated by nicotinic receptors in the ventral tegmental area","volume":"16","author":"Nisell","year":"1994","journal-title":"Synapse"},{"key":"ref_55","unstructured":"Available online:http:\/\/profiles.nlm.nih.gov\/NN\/B\/B\/C\/V\/\/nnbbcv.pdf."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Solanto, M.V., Arnsten, A.F.T., and Castellanos, F.X. (2001). Stimulant Drugs and ADHD: Basic and Clinical Neuroscience, Oxford University Press.","DOI":"10.1093\/oso\/9780195133714.001.0001"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.biopsych.2005.03.036","article-title":"In vivo neuroreceptor imaging in attention-deficit\/hyperactivity disorder: A focus on the dopamine transporter","volume":"57","author":"Spencer","year":"2005","journal-title":"Biol. Psychiatr."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/s00259-002-1047-3","article-title":"Dopamine transporter density in the basal ganglia assessed with [123I]IPT SPECT in children with attention deficit hyperactivity disorder","volume":"30","author":"Cheon","year":"2003","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1016\/S0140-6736(99)04030-1","article-title":"Dopamine transporter density in patients with attention deficit hyperactivityn disorder","volume":"354","author":"Dougherty","year":"1999","journal-title":"Lancet"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1007\/s002590000330","article-title":"Attention deficit hyperactivity disorder: Binding of [99mTc]TRODAT-1 to the dopamine transporter before and aftermethylphenidate treatment","volume":"27","author":"Dresel","year":"2000","journal-title":"Eur. J. Nucl. Med."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1196\/annals.1441.016","article-title":"ADHD and smoking: From genes to brain to behavior","volume":"1141","author":"McClernon","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nrn1298","article-title":"The neurobiology of nicotine addiction: Bridging the gap from molecules to behaviour","volume":"5","author":"Laviolette","year":"2004","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.2105\/AJPH.2009.188136","article-title":"Smoking characteristics of adults with selected lifetime mental illnesses: Results from the 2007 National Health Interview Survey","volume":"100","author":"McClave","year":"2010","journal-title":"Am. J. Public Health"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1080\/165060702321138564","article-title":"Smoking and non-clinical panic attacks: Aninitial empirical test of panic-relevant cognitive processes","volume":"31","author":"Zvolensky","year":"2002","journal-title":"Cogn. Behav. Ther."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/clipsy.10.1.29","article-title":"Panic disorder and smoking","volume":"10","author":"Zvolensky","year":"2003","journal-title":"Clin. Psychol. Sci. Pract."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/0006-3223(95)00519-6","article-title":"Dopamine D2 receptor (DRD2) gene and susceptibility to posttraumatic stress disorder: A study and replication","volume":"40","author":"Comings","year":"1996","journal-title":"Biol. Psychiatr."},{"key":"ref_67","unstructured":"Gilbert, D. (1995). Smoking: Individual Differences, Psychopathology and Emotion, Taylor & Francis."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1017\/S1092852900008841","article-title":"The neuroendocrinology of PTSD\u2014New directions","volume":"8","author":"Rasmusson","year":"2003","journal-title":"CNS Spectr."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.drugalcdep.2003.10.014","article-title":"Prospective examination of effects of smoking abstinence on cortisol and withdrawal symptoms as predictors of early smoking","volume":"73","author":"Hatsukami","year":"2004","journal-title":"Drug Alcohol. Depend."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1176\/ps.50.10.1346","article-title":"A review of the effects of nicotine on schizophrenia and antipsychotic medications","volume":"50","author":"Lyon","year":"1999","journal-title":"Psychiatr. Serv."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0006-3223(97)00423-X","article-title":"Cortisol and response to dexamethasone as predictors of withdrawal distress and abstinence success in smokers","volume":"43","author":"Frederick","year":"1998","journal-title":"Biol. Psychiatr."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/978-3-540-69248-5_6","article-title":"In vivo brain imaging of human exposure to nicotine and tobacco","volume":"192","author":"Sharma","year":"2009","journal-title":"Handb Exp. Pharmacol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.0963-7214.2005.00386.x","article-title":"Cigarette smoking and panic psychopathology","volume":"14","author":"Zvolensky","year":"2005","journal-title":"Curr. Directions Psychol. Sci."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1023\/A:1023456419736","article-title":"Heart-focused anxiety and chest pain in post-angiography medical patients","volume":"26","author":"Zvolensky","year":"2003","journal-title":"J. Behav. Med."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1073\/pnas.94.2.587","article-title":"Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus","volume":"94","author":"Freedman","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1080\/02791072.1999.10471731","article-title":"Smoking and anxiety in combat veterans with chronic posttraumatic stress disorder: A review","volume":"31","author":"Beckham","year":"1999","journal-title":"J. Psychoact. Drugs"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0376-8716(94)90110-4","article-title":"Substance abuse and post-traumatic stress disorder comorbidity","volume":"35","author":"Brown","year":"1994","journal-title":"Drug Alcohol. Depend."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jad.2008.01.018","article-title":"Going up in smoke: Tobacco smoking is associated with worse treatment outcomes in mania","volume":"110","author":"Berk","year":"2008","journal-title":"J. Affect Disord."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1471-2350-11-14","article-title":"Modeling complex genetic and environmental influences on comorbid bipolar disorder with tobacco use disorder","volume":"11","author":"McEachin","year":"2010","journal-title":"BMC Med. Genet."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.genhosppsych.2005.05.003","article-title":"Prevalence and correlates of tobacco use in bipolar disorder: Data from the first 2000 participants in the Systematic Treatment Enhancement Program","volume":"27","author":"Waxmonsky","year":"2005","journal-title":"Gen. Hosp. Psychiatr."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.4088\/JCP.v66n1001","article-title":"Prevalence, correlates, and comorbidity of bipolar I disorder and axis I and II disorder: results from the National Epidemiologic Survey on Alcohol and Related Condition","volume":"66","author":"Grant","year":"2005","journal-title":"J. Clin. Psychiatr."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1399-5618.2009.00664.x","article-title":"Tobacco smoking behaviors in bipolar disorder: A comparison of the general population, schizophrenia, and major depression","volume":"11","author":"Diaz","year":"2009","journal-title":"Bipolar Disord"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/13651500510028977","article-title":"Cigarette smoking and psychiatric disorders in Hungary","volume":"9","author":"Doeme","year":"2005","journal-title":"Int. J. Psychiatr. Clin. Pract."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"269","DOI":"10.4088\/JCP.v62n0409","article-title":"Smoking habits in bipolar and schizophrenic outpatients in southern Israel","volume":"62","author":"Itkin","year":"2001","journal-title":"J. Clin. Psychiatr."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1192\/bjp.bp.109.065912","article-title":"Cigarette smoking and depression: Tests of causal linkages using a longitudinal birth cohort","volume":"196","author":"Boden","year":"2010","journal-title":"Br. J. Psychiatr."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1080\/15504260902869964","article-title":"Biological basis for the co-morbidity between smoking and mood disorders","volume":"5","author":"Mineur","year":"2009","journal-title":"J. Dual Diagn."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1001\/archpsyc.55.2.161","article-title":"Major depression and stages of smoking: Alongitudinal investigation","volume":"55","author":"Breslau","year":"1998","journal-title":"Arch. Gen. Psychiatr."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1017\/S1461145701002188","article-title":"Monoamine oxidases and tobacco smoking","volume":"4","author":"Berlin","year":"2001","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.4088\/JCP.v68n0718","article-title":"A randomized, placebo-controlled clinical trial of bupropion for theprevention of smoking in children and adolescents with attention-deficit\/hyperactivity disorder","volume":"68","author":"Monuteaux","year":"2000","journal-title":"J. Clin. Psychiatr."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0091-3057(00)00205-7","article-title":"The effects of nicotine on neural pathways implicated in depression: A factor in nicotine addiction?","volume":"66","author":"Balfour","year":"2000","journal-title":"Pharmacol. Biochem. Behav."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/0006-3223(94)00365-A","article-title":"Clozapine decreases smoking in patients with chronic schizophrenia","volume":"37","author":"McEvoy","year":"1995","journal-title":"Biol. Psychiatr."},{"key":"ref_92","unstructured":"Anthenelli, R.M., Hill, K.K., Ekhator, N.N., Baker, D.G., Maxwell, R.A., and Geracioti, T.D. (2001, January 23\u201325). A Preliminary Evaluation of Cigarette Smoking\u2019s Effects on Cerebrospinal Fluid  5-Hydroxyindolacetic Acid Concentrations. Proceeding of the 7th Annual Meeting of the Society for Research on Nicotine and Tobacco, Seattle, WA, USA."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1176\/ajp.156.1.130","article-title":"Low CSF concentration of a dopamine metabolite in tobacco smokers","volume":"156","author":"Geracioti","year":"1999","journal-title":"Am. J. Psychiatr."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/00006842-199001000-00002","article-title":"Heart rate reactivity as a predictor of neuroendocrine responses to aversive and appetitive challenges","volume":"52","author":"Lovallo","year":"1990","journal-title":"Psychosom. Med."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1399-5618.2011.00943.x","article-title":"The co-occurrence of cigarette smoking and bipolar disorder: Phenomenology and treatment considerations","volume":"13","author":"Heffner","year":"2011","journal-title":"Bipolar Disord."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1001\/archpsyc.61.11.1107","article-title":"Nicotine dependence and psychiatric disorders in the United States: Results from the National Epidemiologic Survey on Alcohol and Related Conditions","volume":"61","author":"Grant","year":"2004","journal-title":"Arch. Gen. Psychiatr."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1001\/archpsyc.1991.01810360033005","article-title":"Nicotine dependence, major depression, and anxiety in young adults","volume":"48","author":"Breslau","year":"1991","journal-title":"Arch. Gen. Psychiatr."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.2105\/AJPH.90.7.1122","article-title":"Predicting smoking cessation and major depression in nicotine-dependent smokers","volume":"90","author":"Breslau","year":"2000","journal-title":"Am. J. Public Health"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1037\/0022-006X.71.4.657","article-title":"History of depression and smoking cessation outcome: A meta-analysis","volume":"71","author":"Hitsman","year":"2003","journal-title":"J. Consult. Clin. Psychol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1176\/appi.ajp.159.6.947","article-title":"Smoking and depression: An examination of mechanisms of comorbidity","volume":"159","author":"Dierker","year":"2002","journal-title":"Am. J. Psychiatr."},{"key":"ref_101","first-page":"88","article-title":"Noncompetitive functional inhibition at diverse, human nicotinic acetylcholine receptor subtypes by bupropion, phencyclidine, and ibogaine","volume":"288","author":"Fryer","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1001\/archpsyc.55.8.683","article-title":"Nortriptyline and cognitive-behavioral therapy in the treatment of cigarette smoking","volume":"55","author":"Hall","year":"1998","journal-title":"Arch. Gen. Psychiatr."},{"key":"ref_103","first-page":"1021","article-title":"D2 dopamine receptor gene polymorphisms among African-Americans and Mexican-Americans: A lung cancer case-control study","volume":"9","author":"Wu","year":"2000","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"469","DOI":"10.2165\/00023210-200115060-00005","article-title":"Smoking in patients receiving psychotropic medications: A pharmacokinetic perspective","volume":"15","author":"Desai","year":"2001","journal-title":"CNS Drugs"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/hup.1191","article-title":"Factors affecting interindividual differences in clozapine response: A review and case report","volume":"26","author":"Bersani","year":"2011","journal-title":"Hum. Psychopharmacol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/BF02246063","article-title":"Haloperidol increases smoking in patients with schizophrenia","volume":"119","author":"McEvoy","year":"1995","journal-title":"Psychopharmacology (Berl.)"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1124\/mi.6.6.4","article-title":"Nicotinic and opioid receptor interactions in nicotine addiction","volume":"6","author":"McGehee","year":"2006","journal-title":"Mol. Interv."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0920-9964(00)00026-8","article-title":"Antipsychotic medication and smoking prevalence in acutely hospitalized patients with chronic schizophrenia","volume":"46","author":"Combs","year":"2000","journal-title":"Schizophr. Res."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/00041444-200212000-00003","article-title":"Dopamine system genes and attention deficit hyperactivity disorder: A meta-analysis","volume":"12","author":"Maher","year":"2002","journal-title":"Psychiatr. Genet."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"R3","DOI":"10.1016\/S0014-2999(97)81951-6","article-title":"Clozapine increases dopamine release in prefrontal cortex by 5-HT1A receptor activation","volume":"338","author":"Rollema","year":"1997","journal-title":"Eur. J. Pharmacol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.janxdis.2003.07.003","article-title":"Smoking behaviors across anxiety disorders","volume":"18","author":"McCabe","year":"2004","journal-title":"J. Anxiety Disord."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0376-8716(99)00025-3","article-title":"Arterial nicotine kinetics during cigarette smoking and intravenous nicotine administration: Implications for addiction","volume":"56","author":"Rose","year":"1999","journal-title":"Drug Alcohol. Depend."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1017\/S1461145704004742","article-title":"The combinationof nicotine with the D2 antagonist raclopride or the weak D4 antagonist L-745,870 generates a clozapine-like facilitation of NMDA receptor-mediated neurotransmission in pyramidal cells of the rat medial prefrontal cortex","volume":"8","author":"Jardemark","year":"2005","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1177\/070674370905400604","article-title":"Treatment of tobacco dependence in mental health and addictive disorders","volume":"54","author":"Hitsman","year":"2009","journal-title":"Can. J. Psychiatr."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1146\/annurev.clinpsy.032408.153614","article-title":"Treatment of smokers with co-occurring disorders: Emphasis on integration in mental health and addiction treatment settings","volume":"5","author":"Hall","year":"2009","journal-title":"Annu. Rev. Clin. Psychol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.bcp.2009.06.002","article-title":"Nicotinic receptor-based therapeutics and candidates for smoking cessation","volume":"78","author":"Dwoskin","year":"2009","journal-title":"Biochem. Pharmacol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1124\/mol.106.025130","article-title":"Varenicline is a partial agonist at alpha4beta2 and a full agonist at alpha7 neuronal nicotinic receptors","volume":"70","author":"Mihalak","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.1021\/jm050069n","article-title":"Varenicline: An alpha4beta2 nicotinic receptor partial agonist for smoking cessation","volume":"48","author":"Coe","year":"2005","journal-title":"J. Med. Chem."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"7577","DOI":"10.1073\/pnas.1103000108","article-title":"Dstinct contributions of nicotinic acetylcholine receptor subunit alpha4 and subunit alpha6 to the reinforcing effects of nicotine","volume":"108","author":"Exley","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_120","first-page":"1346","article-title":"Aripiprazole, alcohol and substance abuse: A review","volume":"16","author":"Brunetti","year":"2012","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1021\/bi300101r","article-title":"Bupropion binds to two sites in the Torpedo nicotinic acetylcholine receptor transmembrane domain: A photoaffinity labeling study with the bupropion analogue [(125)I]-SADU-3-72","volume":"51","author":"Pandhare","year":"2012","journal-title":"Biochemistry"},{"key":"ref_122","unstructured":"ClinicalTrials.gov. Available online:www.clinicaltrials.gov."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.neulet.2010.02.050","article-title":"Association study of a functional catechol-O-methyltransferase polymorphism and smoking in healthy Caucasian subjects","volume":"473","author":"Nedic","year":"2010","journal-title":"Neurosci. Lett."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"614","DOI":"10.5414\/CPP44614","article-title":"Galantamine reduces smoking in alcohol-dependent patients: A randomized, placebo-controlled trial","volume":"44","author":"Diehl","year":"2006","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.euroneuro.2012.11.013","article-title":"l-Acetylcarnitine in dysthymic disorder in elderly patients: A double-blind, multicenter, controlled randomized study vs. fluoxetine","volume":"23","author":"Bersani","year":"2013","journal-title":"Eur. Neuropsychopharmacol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1176\/ajp.147.5.591","article-title":"Oral S-adenosylmethionine in depression: A randomized, double-blind, placebo-controlled trial","volume":"147","author":"Kagan","year":"1990","journal-title":"Am. J. Psychiatr."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/nn1069","article-title":"Neuroadaptations in cystine-glutamate exchange underlie cocaine relapse","volume":"6","author":"Baker","year":"2003","journal-title":"Nat. Neurosci."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.biopsych.2008.10.040","article-title":"The role of cystine-glutamate exchange in nicotine dependence in rats and humans","volume":"65","author":"Knackstedt","year":"2009","journal-title":"Biol. Psychiatr."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1007\/s00213-005-0226-x","article-title":"Neuroactive steroids, negative affect, and nicotine dependence severity in male smokers","volume":"186","author":"Marx","year":"2006","journal-title":"Psychopharmacology (Berl.)"},{"key":"ref_130","first-page":"131","article-title":"Medications for smoking cessation","volume":"176","author":"Corelli","year":"2002","journal-title":"West J. Med."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.bmc.2003.11.029","article-title":"Investigations using immunization to attenuate the psychoactive effects of nicotine","volume":"12","author":"Carrera","year":"2004","journal-title":"Bioorg. Med. Chem."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s002130051027","article-title":"Smoking behaviour and compensation: A review of the literature","volume":"145","author":"Scherer","year":"1999","journal-title":"Psychopharmacology (Berl.)"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1517\/13543784.15.2.107","article-title":"Neuropharmacology and potential efficacy of new treatments for tobacco dependence","volume":"15","author":"Balfour","year":"2006","journal-title":"Expert Opin. Investig. Drugs"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1524-4733.2009.00672.x","article-title":"The cost-effectiveness of an extended course (12+12 weeks) of varenicline compared with other available smoking cessation strategies in the United States: An extension and update to the BENESCO model","volume":"13","author":"Knight","year":"2010","journal-title":"Value Health."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1111\/j.1360-0443.2010.02946.x","article-title":"Smoking cessation in severe mental illness: What works?","volume":"105","author":"Banham","year":"2010","journal-title":"Addiction"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1192\/bjp.bp.109.066019","article-title":"Efficacy and safety of bupropion for smoking cessation and reduction in schizophrenia: Systematic review and meta-analysis","volume":"196","author":"Tsoi","year":"2010","journal-title":"Br.J. Psychiatr."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1176\/appi.ajp.157.11.1835","article-title":"Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in schizophrenia","volume":"157","author":"George","year":"2000","journal-title":"Am. J. Psychiatr."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1176\/appi.ajp.2007.07020326","article-title":"Exacerbation of schizophrenia by varenicline","volume":"164","author":"Freedman","year":"2007","journal-title":"Am. J. Psychiatr."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.4088\/JCP.v69n0620a","article-title":"Varenicline treatment for smokers with schizophrenia: A case series","volume":"69","author":"Evins","year":"2008","journal-title":"J. Clin. Psychiatr."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.schres.2009.02.001","article-title":"Cognitive and antismoking effects of varenicline in patients with schizophrenia or schizoaffective disorder","volume":"110","author":"Smith","year":"2009","journal-title":"Schizophr. Res."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.biopsych.2008.08.028","article-title":"Varenicline improves mood and cognition during smoking abstinence","volume":"65","author":"Patterson","year":"2009","journal-title":"Biol. Psychiatr."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"52","DOI":"10.4088\/PCC.v10n0109","article-title":"Smoking cessations in patients with psychiatric disorders","volume":"10","author":"Gelenberg","year":"2008","journal-title":"Prim Care Companion J. Clin. Psychiatr."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"S406","DOI":"10.1016\/j.amepre.2007.09.004","article-title":"Nicotine interventions with comorbid populations","volume":"33","author":"Hall","year":"2007","journal-title":"Am. J. Prev. Med."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1037\/0022-006X.69.3.471","article-title":"Cognitive-behavioral treatment for depression in smoking cessation","volume":"69","author":"Brown","year":"2001","journal-title":"J. Consult. Clin. Psychol."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1037\/0022-006X.72.4.563","article-title":"Influences of mood, depression history, and treatment modality on outcomes in smoking cessation","volume":"72","author":"Haas","year":"2004","journal-title":"J. Consult Clin. Psychol."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/00004714-200102000-00017","article-title":"A preliminary study of bupropion sustained-release for smoking cessation in patients with chronic posttraumatic stress disorder","volume":"21","author":"Hertzberg","year":"2001","journal-title":"J. Clin. Psychopharmacol."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1527-3458.2006.00178.x","article-title":"Review of the pharmacology and clinical profile of bupropion, an antidepressant and tobacco use cessation agent","volume":"12","author":"Dwoskin","year":"2006","journal-title":"CNS Drug Rev."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1080\/14622200410001734030","article-title":"The genetic basis for smoking behavior: A systematic review and metaanalysis","volume":"6","author":"Munafo","year":"2004","journal-title":"Nicotine Tob. Res."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.schres.2005.04.016","article-title":"Increased nicotine and cotinine levels in smokers with schizophrenia and schizoaffective disorder is not a metabolic effect","volume":"79","author":"Williams","year":"2005","journal-title":"Schizophr. Res."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.biopsych.2005.10.029","article-title":"ABT-089, a neuronal nicotinic receptor partial agonist, for the treatment of attention-deficit\/hyperactivity disorder in adults: Results of a pilot study","volume":"59","author":"Wilens","year":"2006","journal-title":"Biol. Psychiatr."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.biopsych.2005.01.027","article-title":"Bupropion XL in adults with attention-deficit\/hyperactivity disorder: A randomized, placebo-controlled study","volume":"57","author":"Wilens","year":"2005","journal-title":"Biol. Psychiatr."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1037\/0893-164X.17.4.259","article-title":"Smoking among psychiatric outpatients: Relationship to substance use, diagnosis, and illness severity","volume":"17","author":"Vanable","year":"2003","journal-title":"Psychol. Addict. Behav."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0024-3205(84)90330-8","article-title":"The effects of smoking on ACTH and cortisol secretion","volume":"34","author":"Seyler","year":"1984","journal-title":"Life Sci."},{"key":"ref_154","unstructured":"Peterson, A.L., Vander Weg, M.W., and Jaen, C.R. (2011). Nicotine and Tobacco Dependence, Hogrefe Publishing."}],"container-title":["International Journal of Environmental Research and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1660-4601\/10\/10\/4790\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T21:49:45Z","timestamp":1760219385000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1660-4601\/10\/10\/4790"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,10]]},"references-count":154,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2013,10]]}},"alternative-id":["ijerph10104790"],"URL":"https:\/\/doi.org\/10.3390\/ijerph10104790","relation":{},"ISSN":["1660-4601"],"issn-type":[{"value":"1660-4601","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,10]]}}}